Sobi, an international biopharmaceutical company transforming the lives of people affected by rare diseases, presented an update on the state of newborn screening for Hereditary Tyrosinemia Type 1 (HT-1) in the United States...

Sobi, an international biopharmaceutical company transforming the lives of people affected by rare diseases, announced that investigators will present data from across its rare disease and specialty care portfolio at multiple scientific meetings this Spring...